WO2018194359A1 - Skin-improving composition - Google Patents
Skin-improving composition Download PDFInfo
- Publication number
- WO2018194359A1 WO2018194359A1 PCT/KR2018/004477 KR2018004477W WO2018194359A1 WO 2018194359 A1 WO2018194359 A1 WO 2018194359A1 KR 2018004477 W KR2018004477 W KR 2018004477W WO 2018194359 A1 WO2018194359 A1 WO 2018194359A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- cosmetic composition
- present
- ginseng
- ginsenoside
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention has no side effects, and relates to a composition for improving skin having excellent effects on skin regeneration, skin wrinkle improvement, and skin moisturizing effect.
- cyclooxygenase-2 Cox-2, cyclooxygenase
- MMP matrix metalloproteinase
- NO nitric oxide
- the collagen is present in the extracellular epilepsy as a major substrate protein produced in the fibroblasts of the skin, and important functions include the mechanical strength of the skin, the resistance of connective tissues and the adhesion of tissues, the support of cell adhesion, cell division and differentiation Induction of growth or wound healing) is known.
- This collagen is reduced by the above-mentioned internal and external factors, which are known to be closely related to wrinkle formation of the skin.
- extensive research on skin aging has revealed an important function of collagen in skin.
- the epidermis located at the outermost part of the skin performs protection against various physical, chemical and mechanical stimuli from the outside and prevents excessive release of moisture through the skin.
- This protective function is possible by the normal formation and maintenance of the stratum corneum consisting of keratinocytes.
- the keratinocytes are cells formed by continually proliferating in the stratum basale, while the basal cells move through the stratum corneum, undergoing morphological and functional changes in stages. Keratinocytes are dislodged from the skin, and new keratinocytes from the epidermal substratum repeat the process of epidermis differentiation or keratinization, replacing their function.
- keratinocytes produce natural moisturizing factor (NMF) and intercellular lipids such as ceramides, cholesterol, and fatty acids, and the stratum corneum acts as a barrier to the outside, resulting in a skin barrier. It will function as.
- NMF natural moisturizing factor
- Atopic dermatitis is also an example of dry skin, more fundamentally due to abnormal skin barrier function.
- a lot of researches have been conducted to supply moisture from the outside or minimize the loss of water from the body, focusing on maintaining proper moisture in the skin.
- Moisturizers such as ceramide) or derivatives thereof have been developed and used in the pharmaceutical or cosmetic field.
- the use of such moisturizers are mostly temporary relief of symptoms rather than fundamental treatment, and do not show sufficient effects on the treatment of dry skin and abnormal skin barrier function including atopic dermatitis. Therefore, it is urgent to develop a material that fundamentally regenerates damaged skin barriers.
- the present applicant has intensified the research on ingredients that are safe for the living body and the active ingredients are stable in the formulation, and above all, have a significant improvement effect compared to the active ingredients for improving the existing skin.
- the combination of ginsenosides and glyceryl glucosides which have excellent effects on anti-aging, promotes transepidermal absorption of ginsenosides, thereby doubling their efficacy and significantly improving skin moisturizing effects. Confirmed that can be given at the same time, to complete the present invention.
- An object of the present invention is to cause a skin side effect, to maximize the skin regeneration, skin wrinkle improvement and skin moisturizing effect, to provide a skin improvement composition that can effectively suppress and improve skin aging.
- Still another object of the present invention is to provide a composition for improving skin that can maximize skin penetration by promoting transdermal absorption of ginsenoside, which is a water-soluble active ingredient.
- the present invention provides a cosmetic composition comprising glyceryl glucoside and ginsenoside as an active ingredient.
- composition according to an aspect of the present invention may be a cosmetic composition for improving skin wrinkles.
- composition according to an aspect of the present invention may be a cosmetic composition for moisturizing the skin.
- the present invention has excellent effects and effects on skin regeneration, skin wrinkle improvement, and skin moisturizing effect. These effects and effects correspond to a significant synergistic effect compared to the case where each single ingredient is an active ingredient.
- each of the active ingredients obtained from the components derived from the natural combination does not cause safety problems such as irritation or redness of the skin, but also significantly improves the transdermal absorption of hydrophilic ginsenosides, It is expected to be applicable to the complex functional cosmetic composition of the formulation.
- composition for improving skin according to the present invention will be described below, unless otherwise defined in the technical terms and scientific terms used at this time, has a meaning commonly understood by those of ordinary skill in the art In the following description, descriptions of well-known functions and configurations that may unnecessarily obscure the subject matter of the present invention will be omitted.
- the term 'skin improvement' refers to smoothing the skin surface, giving skin moisturizing and glossiness, and improving skin tone by suppressing or inhibiting roughening of the skin surface under the influence of aging, stress, and the like. In addition, it refers to any action that improves or beneficially changes the skin condition by improving skin wrinkles and enhancing elasticity.
- 'antioxidation' refers to oxidation of cells by highly reactive free radicals or reactive oxygen species (ROS) according to oxidative stress caused by intracellular metabolism or ultraviolet rays. It refers to inhibiting, including the removal of free radicals or reactive oxygen species, thereby reducing damage to the cells.
- ROS reactive oxygen species
- 'wrinkle improvement' refers to inhibiting or inhibiting wrinkles generated on the skin or alleviating wrinkles already generated.
- the "elasticity enhancement” refers to the increase in elasticity to the skin, to inhibit or inhibit the loss of skin elasticity, or to alleviate the already reduced elasticity.
- moisture refers to inhibiting or suppressing the decrease in moisture of the skin or increasing the moisture content of the skin to smooth the surface of the skin and impart gloss.
- 'ginseng Panax ginseng CA Meyer
- ginseng a plant belonging to the genus Ogapiaceae ginseng, and is known to have pharmacological activities such as anticancer, anti-aging, antidiabetic, antistress and neuroprotective effects, and a cosmetic composition. It is known to have wrinkle improvement and whitening efficacy.
- Ginseng in the present invention can be used without limitation in the kind and annual root, can be used both ginseng dried or not dried.
- ginseng in the present invention can be used without limitation to the site, specifically, ginseng root, ginseng flower, leaves or fruits can be used, of course, may be preferably used ginseng root.
- 'white ginseng' means that the epidermis of ginseng is removed and dried
- 'red ginseng black ginseng' is a process of steaming several times and dried several times under warm conditions using ginseng (repeatedly Steamed and dried), and means processed ginseng that has undergone a manufacturing process.
- They increase the content of the active ingredient including ginsenosides during the above-described process, and include nitrogen-containing components, polyacetylene-based compounds, flavonoids, vitamins (eg, vitamin B group), enzymes, organic acids and A high amount of amino acids and the like is preferred in the present invention, but is not limited thereto.
- the term 'extract' used in the present invention is extracted according to a conventional method known in the art by adding an extraction solvent to at least one selected from the leaves, flowers, stems, branches, roots, outposts and fruits of plants. . That is, using a conventional solvent under the conditions of the normal temperature and pressure, cold extraction, ultrasonic extraction, reflux cooling extraction, hot water extraction, room temperature extraction, warm extraction, supercritical extraction may be extracted, but is not limited thereto. It doesn't happen.
- the extraction solvent is not limited thereto, but water, anhydrous or hydrous lower alcohol having 1 to 7 carbon atoms, hexane, chloroform, ethyl ether, acetone, ethyl acetate, butyl acetate, 1,3-butylene glycol, 1,
- 2-propylene glycol, 1,3-propylene glycol, and the like can be used, preferably lower alcohols selected from methanol, ethanol, propanol and butanol, water and the like.
- the extract extracted by the extraction solvent is a concept that includes all the extracts, fractions, purified products, their dilutions, concentrates or dried products obtained in each step of the fraction or purification, in some cases, lyophilization, vacuum drying Hot air drying, spray drying, reduced pressure drying, foam drying, high frequency drying, infrared drying and the like can be dried using a method, and may further have a process of grinding the dried extract.
- the extract is characterized in that it has a liquid, concentrated solid phase and freeze-dried powder form, as the filter has an additional process, such as drying and grinding if desired.
- lipophilic nonionic surfactant and “hydrophilic nonionic surfactant” may be classified and defined by HLB (hydrophilic-lipophilic-balance) value unless otherwise defined.
- the lipophilic nonionic surfactant may have an HLB value of 0 to 10, and preferably may have an HLB value of 2 to 7.
- the hydrophilic nonionic surfactant may have a HLB value of 10 to 20, and preferably may have a HLB value of 13 to 18.
- the term 'comprising as an active ingredient' means a cosmetic composition, which may mean to include an effective amount of the degree that can exhibit the efficacy and effect according to the present invention.
- Glyceryl glucoside is a substance in which glycerol and glucose are combined and is known to exert a whitening effect by inhibiting melanin production or inhibiting activity of the enzyme tyrosinase. Recently, the increase in aquaporin-3 expression by the glyceryl glucoside has been found, attracting attention as a moisturizing component.
- the present applicant is intensifying the study of a cosmetic composition having a new complex functionality by combining the glyceryl glucoside and an additional active ingredient, thereby providing additional functions as well as the effect of the above-mentioned glyceryl glucoside.
- a cosmetic composition having a new complex functionality by combining the glyceryl glucoside and an additional active ingredient, thereby providing additional functions as well as the effect of the above-mentioned glyceryl glucoside.
- ginsenosides it was confirmed that there is synergy in the effects described above.
- the ginsenoside is a type of saponin known as a representative active ingredient of ginseng, is known to have cancer activity and induce regeneration of cancer cells (induce cancer cells to be re-differentiated into healthy cells).
- Heavy Rg3 is known to have a relatively strong inhibitory effect on platelet aggregation induced by collagen and the like.
- Ginsenoside Rhl is also known to have a significant inhibitory effect on the conversion of fibrinogen to fibrin induced by thrombin.
- ginsenosides have been found to be effective as antioxidant effects, promoting collagen production, and are widely used as cosmetic compositions for inhibiting skin aging and improving wrinkles.
- ginsenosides are structurally hydrophilic and have the disadvantage that their effects are temporary or insignificant when applied to cosmetic compositions despite the excellent efficacy described above.
- the cosmetic composition according to the present invention specifically the cosmetic composition comprising glyceryl glucoside and ginsenoside as an active ingredient can effectively solve the problem of the above-mentioned ginsenosides, as well as can significantly improve transdermal absorption. .
- the cosmetic composition according to the present invention can be effectively combined with the effects and effects of various aspects on the biological mechanism in the skin, it can give an excellent skin improvement effect.
- ginsenosides exhibiting structural hydrophilicity. This is expected due to the strong interaction of glyceryl glucoside with ginsenosides.
- the interaction may be a hydrogen bond, an electrostatic attraction, a van der Waals bond, or the like.
- PPD-based ginsenosides such as Rb1, Rb2, Rb3, Rc, and Rd, which are not limited, but preferably have the following structure of the cosmetic composition according to an aspect of the present invention.
- PPT-based ginsenosides such as Rg1, Rg2, Rg3, Rg5, Rg6, Rh1, Rh2, Rh3, Rh4, Rk1 and CK.
- the cosmetic composition according to an aspect of the present invention is glyceryl glucoside; And ginseng, red ginseng, white ginseng and black ginseng may be included alone or mixed extracts.
- the extract extracted from the ginseng, red ginseng, white ginseng, and black ginseng includes the ginsenosides described above.
- the single extract or mixed extract selected from ginseng, red ginseng, white ginseng and black ginseng may be a known method (for example, cold sediment extraction, ultrasonic extraction, reflux cooling extraction, hot water extraction, room temperature extraction, warm extraction, supercritical extraction, etc.). It may be to be extracted.
- the ginseng extract is a step of extracting by heating the ginseng root in a solvent; It may be obtained by a method comprising a; and concentrated under reduced pressure the solution obtained in the step of extracting and freeze drying.
- the solvent is not limited, but as a non-limiting example of water, C 1-7 anhydrous or hydrous lower alcohol, hexane, chloroform, ethyl ether, acetone, ethyl acetate, butyl acetate, 1,3-butylene glycol It may be one or two or more mixed solvents selected from, 1,2-propylene glycol, 1,3-propylene glycol, and the like, preferably 100wt% of water or a hydrous lower alcohol.
- ginsenoside is based on 100 parts by weight of glyceryl glucoside. It may be included in the range of 10 to 200 parts by weight, preferably 30 to 150 parts by weight of ginsenosides, more preferably 50 to 120 parts by weight of ginsenosides.
- the cosmetic composition according to one aspect of the present invention when a single extract or mixed extract of ginseng, red ginseng, white ginseng, and black ginseng simultaneously containing ginsenosides of various embodiments is significant, the effect and effect desired in the present invention are remarkable.
- the present invention is preferred in the present invention.
- the stronger interaction with glyceryl glucoside effectively solves the above-mentioned problems of ginsenosides.
- the active ingredient deep into the skin, by allowing these active ingredients to continuously supply the effect and effect to the skin, it is possible to provide the maximum effect and effect to the aged skin.
- the cosmetic composition according to an aspect of the present invention may further include a polyhydric alcohol.
- the polyhydric alcohol is not limited as long as it is a conventional moisturizing component, non-limiting examples thereof glycerin, 1,3-propanediol, 1,3-butanediol, 1,5-pentanediol, 1,2-hexanediol , 1,8-octanediol and 1,10-decanediol, sorbitol, diglycerin, erythritol, pentaerythritol, polybutyleneglycol-10, polyglycerin-3, polyglycerine-4, polyglycerine-6, polyglycerine -10, polyglycerin-20, polyglycerin-40, inositol, maltitol, met, mannitol, mannose, lactitol, lactose, dihydroxypropyl PG-glucoside, fruct
- the cosmetic composition according to an aspect of the present invention is preferably glycerin, 1,2-hexanediol or these in terms of improving formulation stability with excellent compatibility, and can continuously provide a moisturizing effect by synergy of improved moisturizing power. It is a matter of course that a mixture of may be used, in addition to the mixture further comprising the above-described polyhydric alcohol.
- Cosmetic composition according to an aspect of the present invention may be included in the range of 0.1 to 30% by weight, based on the total weight of the polyhydric alcohol, preferably 0.1 to 20% by weight, more preferably 0.5 to 10% by weight. However, it is not limited thereto.
- the cosmetic composition according to an aspect of the present invention may further include a nonionic surfactant. Accordingly, the cosmetic composition according to the present invention can more effectively promote the stability of the formulation and skin penetration of ginsenosides.
- the nonionic surfactant may be used as one or two or more mixtures selected from lipophilic nonionic surfactants and hydrophilic nonionic surfactants, as well as lipophilic nonionic surfactants and hydrophilic nonionics. It is of course possible to use mixtures of surfactants.
- the cosmetic composition according to an aspect of the present invention comprises an extract extracted from ginseng, red ginseng, white ginseng, black ginseng, etc.
- the nonionic surfactant may have a hydroxyl value (Hydroxy value; measured using OHV, ISO 4629-1978, mg KOH / g) of 250 or less, and preferably 200 or less. It may be, and more preferably may be 50 or more and 150 or less.
- Non-limiting examples of nonionic surfactants satisfying the above conditions include polysorbate, polyoxyethylene-polyoxypropylene, glycerin fatty acid ester, polyoxyethylene-glycerine fatty acid ester, and the like.
- the polysorbate nonionic surfactant may be selected from polysorbate 20, polysorbate 40, polysorbate 60, polysorbate 65, polysorbate 80, polysorbate 85, and the like.
- the total amount of the nonionic surfactant may be included in the range of 0.1 to 10% by weight, based on the total weight of the composition, preferably 0.5 to 10% by weight, more preferably 0.5 to 8% by weight. It is not limited.
- Cosmetic composition according to an aspect of the present invention may be for skin moisturizing.
- glyceryl glucoside or catechin alone when used, it shows a significantly improved skin moisturizing effect and simultaneously provides the above-mentioned effects and effects. That is, according to the present invention, the biological mechanisms in the skin may be complexed, and the effect of brightening the color and skin tone as well as skin moisturization may be exhibited.
- the cosmetic composition according to an aspect of the present invention may further include additional moisturizing ingredients that can help maintain the barrier function caused by external stimulation by promoting the growth and differentiation of the epidermis as well as skin moisturizing. to be.
- the moisturizing component is not limited, and examples thereof include, but are not limited to, isoflavones selected from genistin, dydazine, glycithin, genistein, dyedzein, and glycidane.
- Cosmetic composition according to an aspect of the present invention can be expected to excellent effect on the inhibition and improvement of skin aging, and can be evenly applied to various cosmetics, quasi-drugs, pharmaceuticals and food formulations to provide an effect against anti-aging have.
- the cosmetic composition according to the present invention described above may be prepared in an emulsion formulation or a solubilized formulation.
- the cosmetic composition of the emulsified formulations may include nutrient cosmetics, essences, eye creams, nutrition creams, massage creams, cleansing creams, cleansing foams, etc., and the cosmetic composition of the solubilized formulations, supple cosmetics, astringent cosmetics, cleansing Water, and the like. It is, of course, formulated in the form of a pack, spray or cone stick, and can be prepared in the form of adjuvants which can be applied topically or systemically as commonly used in the field of dermatology.
- the cosmetic composition according to an aspect of the present invention may include a cosmetic composition comprising the glyceryl glucoside and ginsenoside as an active ingredient in the formulation, 0.001 to 50% by weight, preferably 0.01 to 30.0% by weight, More preferably 0.01 to 20.0% by weight.
- each of the cosmetic compositions prepared in the following Examples and Comparative Examples was subjected to three skin permeation tests using the skin of hairless mice. 48 ⁇ l of sample was injected into the skin surface of 7.5 mm in diameter, and the amount of ginsenoside permeated after 24 hours using a transdermal absorption device (Microette, Hanson Co.) was obtained by high-performance liquid chromatography. Quantitatively by graphy, it was calculated as the percent transmittance of ginsenosides (see Table 2).
- each cosmetic composition was 10 ⁇ g / mL and 20 ⁇ g / mL, and the positive control vitamin C was added to the medium so as to be 50 ⁇ g / ml, and a negative control (no addition) was added to each of fibroblasts derived from humans ( 7 ⁇ 10 4 cells / cm 2) were added to the culture medium and incubated for 1 day, and then the culture medium was taken and measured at 450 nm using a spectrophotometer at the concentration of collagen biosynthesis at each concentration using PICP EIA Kit. At this time, the collagen biosynthesis was calculated as the increase rate (%) relative to the negative control ability (see Table 3).
- the test site was defined as a rectangle of 4 x 3 cm 2 on the left and right inner side of the lower chest, and the skin surface capacitance was measured three times using a coneometer (Corneometer, CM825).
- NTdi nth measured value where no sample is applied
- NTd0 before measurement of the area where the sample is not applied
- Formulation stability is circulated once daily at room temperature (20 ⁇ 2 °C), cold and thermostatic bath (4 ⁇ 2 °C), high temperature bath (45 ⁇ 2 °C) and cycle chamber (Freeze-Thaw Chamber, -20 °C to 45 °C). ), And discoloration and phase separation of each sample at a weekly interval were visually observed (see Table 5).
- the cosmetic composition according to the present invention can be seen that the permeability is significantly promoted compared to the comparative example.
- the effect thereof is doubled by further including a polyhydric alcohol and / or a nonionic surfactant.
- the cosmetic composition according to the present invention not only shows excellent collagen synthesis ability for human-derived fibroblasts, but also superior collagen synthesis ability at a lower test concentration than that of vitamin C used as a positive control. It can be seen that.
- the cosmetic composition according to the present invention can be excellent in the skin wrinkle improvement effect, can be expected to maximize the skin improvement effect.
- the above-mentioned efficacy and effect of the cosmetic composition according to the present invention described above corresponds to a surprising synergistic effect compared to the cosmetic composition comprising ginsenoside or glyceryl glucoside alone.
- the cosmetic composition according to the present invention shows a significantly improved short-term moisturizing effect compared to the cosmetic composition comprising ginsenoside or glyceryl glucoside alone.
- glycerin also known as a moisturizing component
- glycerin can exhibit a synergistic effect of up to 109.8% or more, as well as a synergistic effect of up to 126.5% or more by further including a predetermined nonionic surfactant.
- the cosmetic composition according to the present invention is confirmed that the formulation remains stable even after a long time without limiting the temperature and does not cause discoloration of the formulation that can be caused by catechin and the like. can do.
- discoloration was observed in the case of the comparative example as well as the formulation instability of the cosmetic composition.
- the cosmetic composition according to the present invention promotes collagen synthesis of fibroblasts of the skin, promotes the proliferation of skin stem cells, promotes the regeneration of the skin, improves wrinkles, enhances elasticity, and improves the skin with a significantly improved skin moisturizing effect. It is expected to be excellent in the effect of improving the texture, and to be applied to cosmetic compositions of various embodiments to provide a composite functional cosmetic.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a skin-improving composition, the composition according to the present invention exhibiting superb synergistic effects with the effects of dermal fibroblasts for promoting collagen and melanin synthesis, eliminating free-radicals, and improving skin-brightening, thus allowing effective use as a cosmetics composition which can notably improve the skin without any adverse effects.
Description
본 발명은 부작용이 없고, 피부 재생, 피부 주름 개선, 피부 보습 효과에 탁월한 효능을 나타내는 피부 개선용 조성물에 관한 것이다.The present invention has no side effects, and relates to a composition for improving skin having excellent effects on skin regeneration, skin wrinkle improvement, and skin moisturizing effect.
인간의 피부는 나이가 들어감에 따라 여러 가지 내적, 외적 요인에 의한 변화를 겪는다. 내적 요인으로는 신진대사를 조절하는 각종 호르몬의 분비 감소, 면역 세포의 기능과 세포들의 활성 저하 등을 들 수 있으며, 외적 요인으로는 오존층 파괴로 인한 자외선 함량의 증가, 환경 오염이 심화되어 자유 라디칼 및 활성 유해 산소 등의 증가를 들 수 있다. 이러한 내적, 외적 요인으로 인해 생체에 필요한 면역 단백질 및 생체 구성 단백질들의 생합성량이 줄어들게 됨으로써, 피부 두께 감소, 주름 증가 또는 피부 탄력 감소 등의 피부 트러블을 비롯하여 여러 가지 변화, 즉 노화를 일으키게 된다.Human skin undergoes a variety of internal and external changes as it ages. Internal factors include decreased secretion of various hormones that regulate metabolism, decreased function of immune cells and activity of cells. External factors include increased free radicals due to ozone layer destruction and increased environmental pollution. And an increase in active harmful oxygen. Due to these internal and external factors, the amount of biosynthesis of immune proteins and constituent proteins necessary for the living body is reduced, causing various changes, that is, aging, including skin problems such as reduced skin thickness, increased wrinkles, or reduced skin elasticity.
노화가 진행될수록 피부를 구성하는 물질인 콜라겐, 엘라스틴, 히알루론산, 및 당단백질의 함유량 및 배열의 변화 또는 감소하는 증상들이 나타나게 되고, 자유 라디칼 및 활성 유해 산소에 의하여 피부는 산화 스트레스를 받게 된다. 또한 노화의 진행 또는 자외선에 의해서, 피부를 구성하는 대부분의 세포에서 전염증성 사이토카인(proinflammatory cytokine)을 생성하는 효소인 사이클로옥시게나제-2(Cox-2, cyclooxygenase)의 생합성이 증가하고, 이들 염증성 인자에 의해 피부조직을 분해하는 효소인 매트릭스 메탈로프로테아제(MMP, Matrix metalloproteinase)의 생합성이 증가하며, iNOS(inducible nitric oxide synthase)에 의한 NO(nitric oxide)생성이 증가하는 것으로 알려져 있다.As aging progresses, symptoms of changes or decreases in the content and arrangement of collagen, elastin, hyaluronic acid, and glycoproteins constituting the skin appear, and the skin is subjected to oxidative stress by free radicals and active harmful oxygen. In addition, due to the progress of aging or ultraviolet light, the biosynthesis of cyclooxygenase-2 (Cox-2, cyclooxygenase), an enzyme that produces proinflammatory cytokine in most cells constituting the skin, is increased. Biosynthesis of matrix metalloproteinase (MMP), an enzyme that degrades skin tissues by inflammatory factors, increases, and nitric oxide (NO) production by inducible nitric oxide synthase (iNOS) is known to increase.
상기 콜라겐은 피부의 섬유아세포에서 생성되는 주요 기질 단백질로서 세포외 간질에 존재하고, 중요한 기능으로는 피부의 기계적 견고성, 결합조직의 저항력과 조직의 결합력, 세포접착의 지탱, 세포분할과 분화(유기체의 성장 혹은 상처 치유시)의 유도 등이 알려져 있다. 이러한 콜라겐은 상술된 내적, 외적 요인에 의해 감소하며, 이는 피부의 주름 형성과 밀접한 연관이 있다고 알려져 있다. 또한, 근래에 들어 피부 노화에 대한 광범위한 연구가 발전하면서 피부에서의 콜라겐의 중요한 기능이 밝혀지고 있다.The collagen is present in the extracellular epilepsy as a major substrate protein produced in the fibroblasts of the skin, and important functions include the mechanical strength of the skin, the resistance of connective tissues and the adhesion of tissues, the support of cell adhesion, cell division and differentiation Induction of growth or wound healing) is known. This collagen is reduced by the above-mentioned internal and external factors, which are known to be closely related to wrinkle formation of the skin. In addition, in recent years, extensive research on skin aging has revealed an important function of collagen in skin.
콜라겐 합성을 촉진하여 주름 개선 효과를 나타내는 종래 유효성분들로는 레티노산(retinoic acid), TGF(transforming growth factor), 동물 태반 유래의 단백질, 베튤린산(betulinic acid), 클로렐라 추출물 등이 알려져 있다. 그러나, 상기 유효성분들은 피부 적용 시 자극과 발적 등의 안전성의 문제로 사용량의 제한이 있거나, 효과가 미미하여 실질적으로 피부의 콜라겐 합성을 촉진하여 피부 기능을 개선하는 효과를 기대할 수 없는 등의 문제점을 가진다.Conventional active ingredients that promote the collagen synthesis and improve wrinkles are known as retinoic acid, transforming growth factor (TGF), protein from animal placenta, betulinic acid, chlorella extract and the like. However, the active ingredients are limited in the amount of use due to safety problems such as irritation and redness when applying the skin, or the effects are insignificant such that the effect of substantially promoting the collagen synthesis of the skin can not be expected to improve the skin function. Have
또한, 피부의 최외각에 위치하고 있는 표피(epidermis)는 외부의 다양한 물리적, 화학적 및 기계적 자극에 대한 방어와 피부를 통한 체내 수분의 과도한 발산을 막는 보호 기능을 수행하고 있다. 이러한 보호 기능은 각질형성세포로 구성된 각질층이 정상적으로 형성되고 유지됨으로써 가능하다. 상기 각질형성세포는 표피최하층(stratum basale)에서 지속적으로 증식하던 기저세포(basal cell)가 각질층(stratum corneum)으로 이동하면서, 단계적으로 형태 및 기능상의 변화를 거치며 형성된 세포이며, 일정 기간이 지나면 오래된 각질형성세포는 피부에서 탈락되고, 표피 최하층으로부터 올라온 새로운 각질형성세포가 그 기능을 대신하는 표피 분화(epidermis differentiation) 또는 각화(keratinization)의 과정을 반복하게 된다. 이러한 각화과정에서 각질형성세포는 천연보습인자(Natural Moisturizing Factor; NMF)와 세라마이드, 콜레스테롤 및 지방산과 같은 세포 간 지질을 생성하여, 각질층이 외부와의 차단층 역할을 하게 됨으로써 피부장벽(skin barrier)로서의 기능을 하게 된다.In addition, the epidermis located at the outermost part of the skin performs protection against various physical, chemical and mechanical stimuli from the outside and prevents excessive release of moisture through the skin. This protective function is possible by the normal formation and maintenance of the stratum corneum consisting of keratinocytes. The keratinocytes are cells formed by continually proliferating in the stratum basale, while the basal cells move through the stratum corneum, undergoing morphological and functional changes in stages. Keratinocytes are dislodged from the skin, and new keratinocytes from the epidermal substratum repeat the process of epidermis differentiation or keratinization, replacing their function. In this keratinization process, keratinocytes produce natural moisturizing factor (NMF) and intercellular lipids such as ceramides, cholesterol, and fatty acids, and the stratum corneum acts as a barrier to the outside, resulting in a skin barrier. It will function as.
최근, 환경오염, 아파트, 고층 건물과 같은 건조한 환경의 증가, 사회적 스트레스의 증가, 우리나라 특유의 과도한 목욕 문화, 피부 노화 등과 같은 여러 가지 요인에 의해 피부 장벽 기능 이상으로 야기되는 피부 건조증은 점점 더 증가하고 있으며, 증세가 심하여 치료를 필요로 하는 경우 또한 지속적으로 증가하고 있다.Recently, skin dryness caused by abnormal skin barrier function due to various factors such as environmental pollution, increase of dry environment such as apartments and high-rise buildings, increase of social stress, excessive bath culture unique to Korea, skin aging, etc. has been increasing. In addition, cases of severe symptoms that require treatment also continue to increase.
아토피성 피부염 역시 피부 건조증의 일예로, 보다 근본적으로는 피부 장벽 기능의 이상을 주요 원인으로 한다. 이러한 아토피성 피부염을 치료하기 위하여, 종래에는 피부 내 적절한 수분 유지에 중점을 두어 외부로부터 수분을 공급하거나 체내로부터의 수분 손실을 최소화하기 위한 연구가 많이 진행되어 왔으며, 실제로 수분 보유 능력이 있는 세라마이드(ceramide) 또는 그의 유도체와 같은 보습제가 개발되어 제약 또는 화장품 영역에서 사용되고 있다. 그러나, 이와 같은 보습제의 사용은 그 대부분이 근본적인 치료이기보다는 일시적인 증상의 완화에 불과하여, 아토피성 피부염을 포함하는 피부 건조증 및 피부 장벽 기능 이상의 치료에 대한 충분한 효과를 나타내지 못하고 있다. 이에, 손상된 피부 장벽을 근원적으로 재생시켜주는 물질의 개발이 시급한 실정이다.Atopic dermatitis is also an example of dry skin, more fundamentally due to abnormal skin barrier function. In order to treat such atopic dermatitis, a lot of researches have been conducted to supply moisture from the outside or minimize the loss of water from the body, focusing on maintaining proper moisture in the skin. Moisturizers such as ceramide) or derivatives thereof have been developed and used in the pharmaceutical or cosmetic field. However, the use of such moisturizers are mostly temporary relief of symptoms rather than fundamental treatment, and do not show sufficient effects on the treatment of dry skin and abnormal skin barrier function including atopic dermatitis. Therefore, it is urgent to develop a material that fundamentally regenerates damaged skin barriers.
이에, 본 출원인은 생체에 안전하고, 유효성분이 제형 내 안정함은 물론이거니와 무엇보다도 기존의 피부 개선을 위한 유효성분 대비 현저한 개선 효과를 갖는 성분에 대한 연구를 심화하였다. 그 결과, 항노화에 우수한 효과를 갖는 진세노사이드와 글리세릴 글루코사이드를 조합하는 경우, 진세노사이드의 경피흡수(Transepidermal absorption)를 촉진시킴으로써, 이의 효능을 배가시킴은 물론이고, 월등히 향상된 피부 보습 효과를 동시에 부여할 수 있음을 확인하여, 본 발명을 완성하였다.Accordingly, the present applicant has intensified the research on ingredients that are safe for the living body and the active ingredients are stable in the formulation, and above all, have a significant improvement effect compared to the active ingredients for improving the existing skin. As a result, the combination of ginsenosides and glyceryl glucosides, which have excellent effects on anti-aging, promotes transepidermal absorption of ginsenosides, thereby doubling their efficacy and significantly improving skin moisturizing effects. Confirmed that can be given at the same time, to complete the present invention.
본 발명의 목적은 피부 부작용을 유발하지 않으며, 피부 재생, 피부 주름 개선 및 피부 보습 효과를 극대화하여, 피부 노화를 효과적으로 억제하고, 개선할 수 있는 피부 개선용 조성물을 제공하는 것이다.An object of the present invention is to cause a skin side effect, to maximize the skin regeneration, skin wrinkle improvement and skin moisturizing effect, to provide a skin improvement composition that can effectively suppress and improve skin aging.
본 발명의 또 다른 목적은 수용성의 유효성분인 진세노사이드의 경피흡수를 촉진하여 피부침투를 극대화시킬 수 있는 피부 개선용 조성물을 제공하는 것이다.Still another object of the present invention is to provide a composition for improving skin that can maximize skin penetration by promoting transdermal absorption of ginsenoside, which is a water-soluble active ingredient.
상기 목적을 해결하기 위해, 본 발명은 글리세릴 글루코사이드 및 진세노사이드를 유효성분으로 포함하는 화장료 조성물을 제공한다.In order to solve the above object, the present invention provides a cosmetic composition comprising glyceryl glucoside and ginsenoside as an active ingredient.
본 발명의 일 양태에 따른 조성물은 피부 주름 개선용 화장료 조성물일 수 있다.The composition according to an aspect of the present invention may be a cosmetic composition for improving skin wrinkles.
또한 본 발명의 일 양태에 따른 조성물은 피부 보습용 화장료 조성물일 수 있다.In addition, the composition according to an aspect of the present invention may be a cosmetic composition for moisturizing the skin.
본 발명에 따르면, 피부 재생, 피부 주름 개선, 피부 보습 효과에 탁월한 효능·효과를 가진다. 이러한 효능·효과는 각각의 단일 성분을 유효성분으로 하는 경우 대비 현저한 시너지 효과에 해당한다.According to the present invention, it has excellent effects and effects on skin regeneration, skin wrinkle improvement, and skin moisturizing effect. These effects and effects correspond to a significant synergistic effect compared to the case where each single ingredient is an active ingredient.
또한 본 발명에 따르면, 천연 유래 성분으로부터 수득된 각 유효성분들이 조합됨에 따라 피부에 대한 자극이나 발적 등 안전성의 문제를 야기 시키지 않을 뿐 아니라 친수성의 진세노사이드의 경피흡수를 현저하게 향상시킴으로써, 다양한 제형의 복합 기능성 화장료 조성물로 적용할 수 있을 것으로 기대된다.In addition, according to the present invention, as each of the active ingredients obtained from the components derived from the natural combination does not cause safety problems such as irritation or redness of the skin, but also significantly improves the transdermal absorption of hydrophilic ginsenosides, It is expected to be applicable to the complex functional cosmetic composition of the formulation.
본 발명에 따른 피부 개선용 조성물에 대하여 이하 상술하나, 이때 사용되는 기술 용어 및 과학 용어에 있어서 다른 정의가 없다면, 이 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 통상적으로 이해하고 있는 의미를 가지며, 하기의 설명에서 본 발명의 요지를 불필요하게 흐릴 수 있는 공지 기능 및 구성에 대한 설명은 생략한다.With respect to the composition for improving skin according to the present invention will be described below, unless otherwise defined in the technical terms and scientific terms used at this time, has a meaning commonly understood by those of ordinary skill in the art In the following description, descriptions of well-known functions and configurations that may unnecessarily obscure the subject matter of the present invention will be omitted.
본 발명에 있어서, ‘피부 개선’이라 함은 노화, 스트레스 등의 영향으로 피부 표면이 거칠어지는 것을 억제 또는 저해함으로써 피부 표면을 매끄럽게 하고, 피부 보습 및 광택을 부여하며, 피부 톤을 밝게 개선하는 것 뿐 아니라 피부 주름 개선 및 탄력 증진에 의해 피부 상태가 호전되거나 이롭게 변경되는 모든 행위를 말한다.In the present invention, the term 'skin improvement' refers to smoothing the skin surface, giving skin moisturizing and glossiness, and improving skin tone by suppressing or inhibiting roughening of the skin surface under the influence of aging, stress, and the like. In addition, it refers to any action that improves or beneficially changes the skin condition by improving skin wrinkles and enhancing elasticity.
본 발명에 있어서, ‘항산화’라 함은 세포내 대사 또는 자외선의 영향으로 인한 산화적 스트레스에 따라 반응성이 높은 자유 라디칼(free radical) 또는 활성산소종(reactive oxygen species;ROS)에 의한 세포의 산화를 억제하는 것을 말하며, 자유 라디칼 또는 활성산소종을 제거하여 이로 인한 세포의 손상이 감소되는 것을 포함한다.In the present invention, 'antioxidation' refers to oxidation of cells by highly reactive free radicals or reactive oxygen species (ROS) according to oxidative stress caused by intracellular metabolism or ultraviolet rays. It refers to inhibiting, including the removal of free radicals or reactive oxygen species, thereby reducing damage to the cells.
본 발명에 있어서, ‘주름 개선’라 함은 피부에 주름이 생성되는 것을 억제 또는 저해하거나, 이미 생성된 주름을 완화시키는 것을 말한다. 또한 본 발명에 있어서, ‘탄력 증진’라 함은 피부에 대한 탄력성이 증가되는 것으로, 피부 탄력의 손실을 억제 또는 저해하거나, 이미 감소된 탄력을 완화시키는 것을 말한다.In the present invention, 'wrinkle improvement' refers to inhibiting or inhibiting wrinkles generated on the skin or alleviating wrinkles already generated. In addition, in the present invention, the "elasticity enhancement" refers to the increase in elasticity to the skin, to inhibit or inhibit the loss of skin elasticity, or to alleviate the already reduced elasticity.
본 발명에 있어서, ‘보습’이라 함은 피부의 수분이 감소되는 것을 저해 또는 억제하거나 피부의 수분 함유량을 증가시켜 피부 표면을 매끄럽게 하며, 윤기를 부여하는 것을 말한다.In the present invention, the term "moisture" refers to inhibiting or suppressing the decrease in moisture of the skin or increasing the moisture content of the skin to smooth the surface of the skin and impart gloss.
본 발명에서 사용되는 용어, ‘인삼(Panax ginseng C.A. Meyer)’은 오가피과 인삼 속에 속하는 식물로, 항암, 항노화, 항당뇨, 항스트레스 및 신경보호 효과 등의 약리 활성을 가진 것으로 알려져 있으며, 화장료 조성물에 있어서는 주름 개선 및 미백 효능을 가진 것으로 알려져 있다. 본 발명에서의 인삼은 그 종류 및 년근에 제한 없이 사용가능하며, 말리거나 말리지 않은 인삼을 모두 사용할 수 있다. 또한 본 발명에서의 인삼은 그 부위에 제한없이 사용 가능하며, 구체적으로 인삼근, 인삼 꽃, 잎 또는 열매를 이용할 수 있음은 물론이며, 좋게는 인삼근을 이용하는 것일 수 있다.The term 'ginseng (Panax ginseng CA Meyer)' used in the present invention is a plant belonging to the genus Ogapiaceae ginseng, and is known to have pharmacological activities such as anticancer, anti-aging, antidiabetic, antistress and neuroprotective effects, and a cosmetic composition. It is known to have wrinkle improvement and whitening efficacy. Ginseng in the present invention can be used without limitation in the kind and annual root, can be used both ginseng dried or not dried. In addition, ginseng in the present invention can be used without limitation to the site, specifically, ginseng root, ginseng flower, leaves or fruits can be used, of course, may be preferably used ginseng root.
또한, 본 발명에서 사용되는 용어, ‘백삼’은 인삼의 표피를 제거하고 건조시킨 것을 의미하며, ‘홍삼, 흑삼’은 인삼을 사용하여 가온 조건에서 수 회 증숙하고 수 회 건조하는 공정(반복적으로 증숙 및 건조)을 거쳐 생산된 것으로, 제조 공정을 거친 가공된 인삼을 의미한다. 이들은 상술된 공정을 반복하는 동안 진세노사이드(ginsenoside)를 포함하는 유효성분의 함량을 높이고, 함질소 성분, 폴리아세틸렌계 화합물, 플라보노이드류, 비타민류(예컨대, 비타민 B군), 효소, 유기산 및 아미노산 등이 다량 함유하여 본 발명에서 우선되나 이에 한정되는 것은 아니다.In addition, the term used in the present invention, 'white ginseng' means that the epidermis of ginseng is removed and dried, 'red ginseng, black ginseng' is a process of steaming several times and dried several times under warm conditions using ginseng (repeatedly Steamed and dried), and means processed ginseng that has undergone a manufacturing process. They increase the content of the active ingredient including ginsenosides during the above-described process, and include nitrogen-containing components, polyacetylene-based compounds, flavonoids, vitamins (eg, vitamin B group), enzymes, organic acids and A high amount of amino acids and the like is preferred in the present invention, but is not limited thereto.
또한, 본 발명에서 사용되는 용어, ‘추출물’은 식물의 잎, 꽃, 줄기, 가지, 뿌리, 전초 및 열매 등에서 선택되는 하나 이상에 추출용매를 가하여 당업계에 공지된 통상의 방법에 따라 추출된다. 즉, 통상적인 온도와 압력의 조건하에서 통상적인 용매를 사용하여, 냉침추출, 초음파추출, 환류 냉각추출, 열수추출, 실온추출, 가온추출, 초임계 추출 등의 방법으로 추출되는 것일 수 있으나 이에 한정되는 것은 아니다. 이때, 상기 추출용매는 이에 한정되는 것은 아니나, 물, 탄소수 1~7개의 무수 또는 함수 저급 알코올, 헥산, 클로로포름, 에틸에테르, 아세톤, 에틸아세테이트, 부틸아세테이트, 1,3-부틸렌 글리콜, 1,2-프로필렌 글리콜 및 1,3-프로필렌 글리콜 등으로 구성된 군으로부터 선택되는 하나 이상을 사용할 수 있으며, 바람직하게는 메탄올, 에탄올, 프로판올 및 부탄올에서 선택되는 저급 알코올과 물 등이 좋다. 또한, 상기 추출용매에 의해 추출된 추출물은 분획 또는 정제의 각 단계에서 얻어지는 모든 추출물, 분획물, 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념으로, 경우에 따라서, 이들을 동결건조, 진공건조, 열풍건조, 분무건조, 감압건조, 포말건조, 고주파건조, 적외선 건조 등의 방법을 사용하여 건조 가능하며, 건조된 추출물을 분쇄하는 과정을 더 가질 수 있다. 따라서, 상기 추출물은 여과 후 경우에 따라 건조 및 분쇄 과정과 같은 추가적인 과정을 가짐에 따라, 액상, 농축된 고상 및 동결 건조된 분말 형태를 갖는 것을 특징으로 한다.In addition, the term 'extract' used in the present invention is extracted according to a conventional method known in the art by adding an extraction solvent to at least one selected from the leaves, flowers, stems, branches, roots, outposts and fruits of plants. . That is, using a conventional solvent under the conditions of the normal temperature and pressure, cold extraction, ultrasonic extraction, reflux cooling extraction, hot water extraction, room temperature extraction, warm extraction, supercritical extraction may be extracted, but is not limited thereto. It doesn't happen. At this time, the extraction solvent is not limited thereto, but water, anhydrous or hydrous lower alcohol having 1 to 7 carbon atoms, hexane, chloroform, ethyl ether, acetone, ethyl acetate, butyl acetate, 1,3-butylene glycol, 1, One or more selected from the group consisting of 2-propylene glycol, 1,3-propylene glycol, and the like can be used, preferably lower alcohols selected from methanol, ethanol, propanol and butanol, water and the like. In addition, the extract extracted by the extraction solvent is a concept that includes all the extracts, fractions, purified products, their dilutions, concentrates or dried products obtained in each step of the fraction or purification, in some cases, lyophilization, vacuum drying Hot air drying, spray drying, reduced pressure drying, foam drying, high frequency drying, infrared drying and the like can be dried using a method, and may further have a process of grinding the dried extract. Thus, the extract is characterized in that it has a liquid, concentrated solid phase and freeze-dried powder form, as the filter has an additional process, such as drying and grinding if desired.
본 발명에서 사용되는 용어, ‘친유성의 비이온 계면활성제’및 ‘친수성의 비이온 계면활성제’는 다른 정의가 없는 한 HLB(hydrophilic-lipophilic-balance) 수치에 의해 분류되고 정의될 수 있다. 이때, 상기 친유성의 비이온 계면활성제는 0 내지 10의 HLB값을 가지는 것일 수 있으며, 바람직하게는 2 내지 7의 HLB 값을 가질 수 있다. 또한, 친수성의 비이온 계면활성제는 10 내지 20의 HLB값을 가지는 것일 수 있으며, 바람직하게는 13 내지 18의 HLB 값을 가지는 것일 수 있다.As used herein, the terms "lipophilic nonionic surfactant" and "hydrophilic nonionic surfactant" may be classified and defined by HLB (hydrophilic-lipophilic-balance) value unless otherwise defined. In this case, the lipophilic nonionic surfactant may have an HLB value of 0 to 10, and preferably may have an HLB value of 2 to 7. In addition, the hydrophilic nonionic surfactant may have a HLB value of 10 to 20, and preferably may have a HLB value of 13 to 18.
본 발명에서 사용되는 용어, ‘유효성분으로 포함하는’의 의미는 화장료 조성물로써, 본 발명에 따른 효능·효과를 나타낼 수 있는 정도의 유효량을 포함하는 것을 의미하는 것일 수 있다.As used herein, the term 'comprising as an active ingredient' means a cosmetic composition, which may mean to include an effective amount of the degree that can exhibit the efficacy and effect according to the present invention.
글리세릴 글루코사이드는 글리세롤과 글루코스가 결합된 물질로, 멜라닌의 생성 저해 또는 효소 티로시나제의 활성 억제 작용을 하여, 미백 효과를 발휘하는 것으로 알려져 있다. 최근 상기 글리세릴 글루코사이드에 의한 아쿠아포린-3(aquaporin-3) 발현 증가가 밝혀짐으로써, 보습 성분으로도 주목받고 있다.Glyceryl glucoside is a substance in which glycerol and glucose are combined and is known to exert a whitening effect by inhibiting melanin production or inhibiting activity of the enzyme tyrosinase. Recently, the increase in aquaporin-3 expression by the glyceryl glucoside has been found, attracting attention as a moisturizing component.
이에, 본 출원인은 상기 글리세릴 글루코사이드와 추가의 유효성분을 조합하여, 상술된 글리세릴 글루코사이드의 효과의 상승 뿐 아니라 추가의 기능을 부여함으로써, 새로운 복합 기능성을 갖는 화장료 조성물에 대한 연구를 심화하던 중 진세노사이드와의 조합에서 상술된 효과에 있어 시너지를 나타냄을 확인하였다.Accordingly, the present applicant is intensifying the study of a cosmetic composition having a new complex functionality by combining the glyceryl glucoside and an additional active ingredient, thereby providing additional functions as well as the effect of the above-mentioned glyceryl glucoside. In combination with ginsenosides, it was confirmed that there is synergy in the effects described above.
상기 진세노사이드(ginsenoside)는 인삼의 대표적인 유효성분으로 알려진 사포닌의 한 종류로서, 암 활성을 갖고 암세포의 재분화를 유도(암 세포가 건강한 세포로 재분화 되도록 유도)할 수 있다고 알려져 있으며, 진세노사이드 중 Rg3는 콜라겐 등에 의해 유도되는 혈소판 응집에 대한 비교적 강한 억제 효과를 갖는다고 알려져 있다. 또한 진세노사이드 Rh1은 트롬빈에 의해 유도되는 피브리노겐의 피브린으로의 전환에 대해 상당한 저해 효과를 갖는다고 알려져 있다.The ginsenoside (ginsenoside) is a type of saponin known as a representative active ingredient of ginseng, is known to have cancer activity and induce regeneration of cancer cells (induce cancer cells to be re-differentiated into healthy cells). Heavy Rg3 is known to have a relatively strong inhibitory effect on platelet aggregation induced by collagen and the like. Ginsenoside Rhl is also known to have a significant inhibitory effect on the conversion of fibrinogen to fibrin induced by thrombin.
이러한 진세노사이드는 항산화 효과, 콜라겐 생성촉진 등의 효능이 밝혀져 피부 노화억제 및 주름개선용 화장료 조성물로 널리 활용되고 있다. 그러나 진세노사이드는 구조적으로 친수성의 특징으로 가져, 상술된 우수한 효능에도 불구하고 화장료 조성물에 적용시 이의 효과가 한시적이거나 미미하다는 단점을 가진다.These ginsenosides have been found to be effective as antioxidant effects, promoting collagen production, and are widely used as cosmetic compositions for inhibiting skin aging and improving wrinkles. However, ginsenosides are structurally hydrophilic and have the disadvantage that their effects are temporary or insignificant when applied to cosmetic compositions despite the excellent efficacy described above.
그러나 본 발명에 따른 화장료 조성물, 구체적으로 글리세릴 글루코사이드 및 진세노사이드를 유효성분으로 포함하는 화장료 조성물은 상술된 진세노사이드의 문제를 효과적으로 해결할 수 있음은 물론, 경피흡수를 현저하게 향상시킬 수 있다. 이에, 본 발명에 따른 화장료 조성물은 다양한 양태의 효능·효과가 복합적으로 피부 속 생물학적 매커니즘에 영향을 주어, 탁월한 피부 개선 효과를 부여할 수 있다.However, the cosmetic composition according to the present invention, specifically the cosmetic composition comprising glyceryl glucoside and ginsenoside as an active ingredient can effectively solve the problem of the above-mentioned ginsenosides, as well as can significantly improve transdermal absorption. . Thus, the cosmetic composition according to the present invention can be effectively combined with the effects and effects of various aspects on the biological mechanism in the skin, it can give an excellent skin improvement effect.
또한 본 발명에 따르면, 각 성분의 단순 배합에 따른 예상치 못한 상승효과를 나타낸다. 구체적으로, 본 발명에 따르면 피부 재생, 피부 주름 개선, 피부 탄력 증진, 피부 보습 효과에 있어서, 각 성분을 단일 성분으로 포함하는 경우 대비 현저하게 향상된 효과를 나타낸다.In addition, according to the present invention, there is an unexpected synergistic effect by a simple combination of each component. Specifically, according to the present invention, in the skin regeneration, skin wrinkle improvement, skin elasticity enhancement, skin moisturizing effect, it shows a remarkably improved effect compared to the case of including each component as a single component.
더욱이, 본 발명에 따르면 구조적으로 친수성을 보이는 진세노사이드의 경피흡수를 획기적으로 촉진할 수 있다. 이는 글리세릴 글루코사이드와 진세노사이드의 강력한 상호작용에 의한 것으로, 예상된다. 상기 상호작용은 수소결합, 정전기적인 인력에 의한 결합, 반데르발스 결합 등일 수 있다.Moreover, according to the present invention, it is possible to dramatically promote the percutaneous absorption of ginsenosides exhibiting structural hydrophilicity. This is expected due to the strong interaction of glyceryl glucoside with ginsenosides. The interaction may be a hydrogen bond, an electrostatic attraction, a van der Waals bond, or the like.
본 발명의 일 양태에 따른 화장료 조성물의 상기 진세노사이드의 종류는 제한되지는 않으나 좋게는 하기 구조를 갖는 Rb1, Rb2, Rb3, Rc 및 Rd 등의 PPD계 진세노사이드; 및 Rg1, Rg2, Rg3, Rg5, Rg6, Rh1, Rh2, Rh3, Rh4, Rk1 및 CK 등의 PPT계 진세노사이드에서 선택되는 하나 또는 둘 이상의 혼합물일 수 있다.PPD-based ginsenosides such as Rb1, Rb2, Rb3, Rc, and Rd, which are not limited, but preferably have the following structure of the cosmetic composition according to an aspect of the present invention; And PPT-based ginsenosides such as Rg1, Rg2, Rg3, Rg5, Rg6, Rh1, Rh2, Rh3, Rh4, Rk1 and CK.
[PPD계 진세노사이드(PROTOPANAXADIOL-TYPE GINSENOSIDE)][PPD series ginsenoside (PROTOPANAXADIOL-TYPE GINSENOSIDE)]
[PPT계 진세노사이드(PROTOPANAXATRIOL-TYPE GINSENOSIDE)][PPT series ginsenoside (PROTOPANAXATRIOL-TYPE GINSENOSIDE)]
또한, 본 발명의 일 양태에 따른 화장료 조성물은 글리세릴 글루코사이드; 및 인삼, 홍삼, 백삼 및 흑삼 등에서 선택되는 단독 추출물 또는 혼합 추출물을 포함하는 것일 수 있다. 이때, 상기 인삼, 홍삼, 백삼 및 흑삼 등에서 추출된 추출물은 상술된 진세노사이드를 포함한다.In addition, the cosmetic composition according to an aspect of the present invention is glyceryl glucoside; And ginseng, red ginseng, white ginseng and black ginseng may be included alone or mixed extracts. At this time, the extract extracted from the ginseng, red ginseng, white ginseng, and black ginseng includes the ginsenosides described above.
상기 인삼, 홍삼, 백삼 및 흑삼 등에서 선택되는 단독 추출물 또는 혼합 추출물은 공지의 방법(예컨대, 냉침추출, 초음파추출, 환류 냉각추출, 열수추출, 실온추출, 가온추출, 초임계 추출 등의 방법)으로 추출되는 것일 수 있다. The single extract or mixed extract selected from ginseng, red ginseng, white ginseng and black ginseng may be a known method (for example, cold sediment extraction, ultrasonic extraction, reflux cooling extraction, hot water extraction, room temperature extraction, warm extraction, supercritical extraction, etc.). It may be to be extracted.
일예로, 상기 인삼 추출물은 용매에 인삼근을 투입하여 가열 추출하는 단계; 및 상기 추출하는 단계에서 수득된 용액을 감압농축한 후 동결 건조하는 단계;를 포함하는 방법으로 수득될 수 있다.For example, the ginseng extract is a step of extracting by heating the ginseng root in a solvent; It may be obtained by a method comprising a; and concentrated under reduced pressure the solution obtained in the step of extracting and freeze drying.
이때, 상기 용매는 제한되지 않으나, 이의 비한정적인 일예로 물, 탄소수 1~7개의 무수 또는 함수 저급 알코올, 헥산, 클로로포름, 에틸에테르, 아세톤, 에틸아세테이트, 부틸아세테이트, 1,3-부틸렌 글리콜, 1,2-프로필렌 글리콜 및 1,3-프로필렌 글리콜 등에서 선택되는 하나 또는 둘 이상의 혼합용매일 수 있으며, 좋게는 100wt%의 물 또는 함수 저급 알코올일 수 있다.At this time, the solvent is not limited, but as a non-limiting example of water, C 1-7 anhydrous or hydrous lower alcohol, hexane, chloroform, ethyl ether, acetone, ethyl acetate, butyl acetate, 1,3-butylene glycol It may be one or two or more mixed solvents selected from, 1,2-propylene glycol, 1,3-propylene glycol, and the like, preferably 100wt% of water or a hydrous lower alcohol.
본 발명의 일 양태에 따른 화장료 조성물에서 상기 글리세릴 글루코사이드 및 진세노사이드의 사용량은 제한되지는 않으나, 상술된 효능·효과를 극대화하기 위한 측면에서, 글리세릴 글루코사이드 100 중량부를 기준으로, 진세노사이드을 10 내지 200 중량부 범위로 포함할 수 있으며, 좋게는 진세노사이드을 30 내지 150 중량부 범위로, 보다 좋게는 진세노사이드을 50 내지 120 중량부 범위로 포함할 수 있다.Although the amount of the glyceryl glucoside and ginsenoside used in the cosmetic composition according to an embodiment of the present invention is not limited, in terms of maximizing the above-described effects and effects, ginsenoside is based on 100 parts by weight of glyceryl glucoside. It may be included in the range of 10 to 200 parts by weight, preferably 30 to 150 parts by weight of ginsenosides, more preferably 50 to 120 parts by weight of ginsenosides.
본 발명의 일 양태에 따른 화장료 조성물에 있어서, 다양한 양태의 진세노사이드을 동시에 포함하는 인삼, 홍삼, 백삼 및 흑삼 등의 단독 추출물 또는 혼합 추출물을 포함하는 경우, 본 발명에서 목적하는 효능·효과에 현저함을 보여 본 발명에서 우선된다. In the cosmetic composition according to one aspect of the present invention, when a single extract or mixed extract of ginseng, red ginseng, white ginseng, and black ginseng simultaneously containing ginsenosides of various embodiments is significant, the effect and effect desired in the present invention are remarkable. The present invention is preferred in the present invention.
본 발명의 일 양태에 따른 화장료 조성물에 있어서, 인삼, 홍삼, 백삼 및 흑삼 등에서 추출된 추출물을 포함하는 경우, 글리세릴 글루코사이드와의 보다 강력한 상호작용으로 상술된 진세노사이드의 문제점을 효과적으로 해결함을 물론이고, 피부 깊숙이 유효성분을 침투시킴으로써, 이들 유효성분이 피부에 지속적으로 효능·효과를 공급케 함으로써, 노화된 피부에 극대화된 효능·효과를 제공할 수 있다.In the cosmetic composition according to an aspect of the present invention, in the case of including the extract extracted from ginseng, red ginseng, white ginseng and black ginseng, the stronger interaction with glyceryl glucoside effectively solves the above-mentioned problems of ginsenosides. Of course, by penetrating the active ingredient deep into the skin, by allowing these active ingredients to continuously supply the effect and effect to the skin, it is possible to provide the maximum effect and effect to the aged skin.
본 발명의 일 양태에 따른 화장료 조성물은 다가 알코올을 더 포함할 수 있다. 이때, 상기 다가 알코올은 통상의 보습 성분이라면 제한되지 않으며, 이의 비한정적인 일예로는 글리세린, 1,3-프로판디올, 1,3-부탄디올, 1,5-펜탄디올, 1,2-헥산디올, 1,8-옥탄디올 및 1,10-데칸디올, 솔비톨, 디글리세린, 에리스리톨, 펜타에리스리톨, 폴리부틸렌글아리콜-10, 폴리글리세린-3, 폴리글리세린-4, 폴리글리세린-6, 폴리글리세린-10, 폴리글리세린-20, 폴리글리세린-40, 이노시톨, 말티톨, 만난, 만니톨, 만노스, 락티톨, 락토스, 디하이드록시프로필 PG-글루코사이드, 프럭토스, 글루카민, 메칠글루카민, 글루코스, 자일리톨 등을 들 수 있다. The cosmetic composition according to an aspect of the present invention may further include a polyhydric alcohol. At this time, the polyhydric alcohol is not limited as long as it is a conventional moisturizing component, non-limiting examples thereof glycerin, 1,3-propanediol, 1,3-butanediol, 1,5-pentanediol, 1,2-hexanediol , 1,8-octanediol and 1,10-decanediol, sorbitol, diglycerin, erythritol, pentaerythritol, polybutyleneglycol-10, polyglycerin-3, polyglycerine-4, polyglycerine-6, polyglycerine -10, polyglycerin-20, polyglycerin-40, inositol, maltitol, met, mannitol, mannose, lactitol, lactose, dihydroxypropyl PG-glucoside, fructose, glucamine, methylglucamine, glucose, xylitol, etc. Can be mentioned.
특히, 본 발명의 일 양태에 따른 화장료 조성물은 우수한 상용성으로 제형 안정성을 높이고, 향상된 보습력의 상승작용으로 보습 효과를 지속적으로 제공할 수 있다는 측면에서 좋게는 글리세린, 1,2-헥산디올 또는 이들의 혼합물을 사용할 수 있으며, 이외 상술된 다가 알코올을 더 포함하는 혼합물을 사용할 수 있음은 물론이다.In particular, the cosmetic composition according to an aspect of the present invention is preferably glycerin, 1,2-hexanediol or these in terms of improving formulation stability with excellent compatibility, and can continuously provide a moisturizing effect by synergy of improved moisturizing power. It is a matter of course that a mixture of may be used, in addition to the mixture further comprising the above-described polyhydric alcohol.
본 발명의 일 양태에 따른 화장료 조성물은 상기 다가 알코올을 조성물 총 중량을 기준으로 0.1 내지 30 중량% 범위로 포함될 수 있으며, 좋게는 0.1 내지 20 중량%, 보다 좋게는 0.5 내지 10 중량%로 포함될 수 있으나 이에 한정되는 것은 아니다.Cosmetic composition according to an aspect of the present invention may be included in the range of 0.1 to 30% by weight, based on the total weight of the polyhydric alcohol, preferably 0.1 to 20% by weight, more preferably 0.5 to 10% by weight. However, it is not limited thereto.
또한, 본 발명의 일 양태에 따른 화장료 조성물은 비이온 계면활성제를 더 포함할 수 있다. 이에 따라, 본 발명에 다른 화장료 조성물은 제형의 안정도 및 진세노사이드의 피부 침투를 보다 효과적으로 촉진시킬 수 있다. In addition, the cosmetic composition according to an aspect of the present invention may further include a nonionic surfactant. Accordingly, the cosmetic composition according to the present invention can more effectively promote the stability of the formulation and skin penetration of ginsenosides.
이때, 상기 비이온 계면활성제는 친유성의 비이온 계면활성제 및 친수성의 비이온 계면활성제에서 선택되는 하나 또는 둘 이상의 혼합물로 사용할 수 있음은 물론이고, 친유성의 비이온 계면활성제와 친수성의 비이온 계면활성제의 혼합물을 사용할 수 있음은 물론이다. In this case, the nonionic surfactant may be used as one or two or more mixtures selected from lipophilic nonionic surfactants and hydrophilic nonionic surfactants, as well as lipophilic nonionic surfactants and hydrophilic nonionics. It is of course possible to use mixtures of surfactants.
특히, 본 발명의 일 양태에 따른 화장료 조성물에서 인삼, 홍삼, 백삼, 흑삼 등에서 추출된 추출물을 포함하는 경우, 상기 다가 알코올 및 상기 비이온 계면활성제를 동시에 사용함에 따라 상술된 효과에서 예기치 못한 현저성을 보인다. In particular, when the cosmetic composition according to an aspect of the present invention comprises an extract extracted from ginseng, red ginseng, white ginseng, black ginseng, etc., unexpected remarkable effects in the above-described effects by using the polyhydric alcohol and the nonionic surfactant simultaneously Seems.
본 발명의 일 양태에 따른 화장료 조성물에서 상기 비이온 계면활성제는 하이드록시가(Hydroxy value; OHV, ISO 4629-1978을 사용하여 측정, mg KOH/g)가 250이하인 것일 수 있으며, 좋게는 200이하인 것 일 수 있으며, 보다 좋게는 50 이상 150 이하인 것일 수 있다.In the cosmetic composition according to an aspect of the present invention, the nonionic surfactant may have a hydroxyl value (Hydroxy value; measured using OHV, ISO 4629-1978, mg KOH / g) of 250 or less, and preferably 200 or less. It may be, and more preferably may be 50 or more and 150 or less.
상기의 조건을 만족하는 비이온 계면활성제의 비한정적인 일예로 폴리소르베이트계, 폴리옥시에틸렌-폴리옥시프로필렌계, 글리세린지방산 에스테르계, 폴리옥시에틸렌-글리세린지방산 에스테르계 등을 들 수 있으며, 좋게는 폴리소르베이트계 비이온 계면활성제로 폴리소르베이트 20, 폴리소르베이트 40, 폴리소르베이트 60, 폴리소르베이트 65, 폴리소르베이트 80, 폴리소르베이트 85 등에서 선택되는 것일 수 있으나 이에 한정되는 않는다.Non-limiting examples of nonionic surfactants satisfying the above conditions include polysorbate, polyoxyethylene-polyoxypropylene, glycerin fatty acid ester, polyoxyethylene-glycerine fatty acid ester, and the like. The polysorbate nonionic surfactant may be selected from polysorbate 20, polysorbate 40, polysorbate 60, polysorbate 65, polysorbate 80, polysorbate 85, and the like.
이때, 상기 비이온 계면활성제의 총 사용량은 조성물 총 중량에 대하여, 각각 0.1 내지 10 중량% 범위로 포함될 수 있으며, 좋게는 0.5 내지 10 중량%, 보다 좋게는 0.5 내지 8 중량%로 포함될 수 있으나 이에 한정되는 것은 아니다.In this case, the total amount of the nonionic surfactant may be included in the range of 0.1 to 10% by weight, based on the total weight of the composition, preferably 0.5 to 10% by weight, more preferably 0.5 to 8% by weight. It is not limited.
본 발명의 일 양태에 따른 화장료 조성물은 피부 보습용일 수 있다. 본 발명에 따르면, 글리세릴 글루코사이드 또는 카테킨을 단독으로 사용하는 경우 보다 현저하게 향상된 피부 보습 효능을 나타내며, 상술된 효능·효과를 동시에 제공한다. 즉, 본 발명에 따르면 복합적으로 피부 속 생물학적 메커니즘에 영향을 주어, 피부 보습 뿐 아니라 혈색 및 피부톤을 밝게 개선하는 효과를 나타낼 수 있다.Cosmetic composition according to an aspect of the present invention may be for skin moisturizing. According to the present invention, when glyceryl glucoside or catechin alone is used, it shows a significantly improved skin moisturizing effect and simultaneously provides the above-mentioned effects and effects. That is, according to the present invention, the biological mechanisms in the skin may be complexed, and the effect of brightening the color and skin tone as well as skin moisturization may be exhibited.
더불어, 본 발명의 일 양태에 따른 화장료 조성물은 피부 보습은 물론이고, 표피의 증식과 분화를 촉진시켜 외부 자극에 의한 장벽기능을 유지를 도울 수 있는 추가의 보습 성분을 더 포함할 수 있음은 물론이다.In addition, the cosmetic composition according to an aspect of the present invention may further include additional moisturizing ingredients that can help maintain the barrier function caused by external stimulation by promoting the growth and differentiation of the epidermis as well as skin moisturizing. to be.
상기 보습 성분은 제한되지는 않으나, 비한정적인 일예로 제니스틴, 다이드진, 그리시틴, 제니스테인, 다이드제인, 그리시테인에서 선택되는 이소플라본류 등을 들 수 있다.The moisturizing component is not limited, and examples thereof include, but are not limited to, isoflavones selected from genistin, dydazine, glycithin, genistein, dyedzein, and glycidane.
본 발명의 일 양태에 따른 화장료 조성물은 피부 노화의 억제 및 개선에 탁월한 효과를 기대할 수 있게 하며, 항노화에 대한 효과를 제공하고자 하는 각종 화장품, 의약외품, 의약품 및 식품 등의 제형에 골고루 응용될 수 있다.Cosmetic composition according to an aspect of the present invention can be expected to excellent effect on the inhibition and improvement of skin aging, and can be evenly applied to various cosmetics, quasi-drugs, pharmaceuticals and food formulations to provide an effect against anti-aging have.
일예로, 상술된 본 발명에 따른 화장료 조성물은 유화 제형 또는 가용화 제형으로 제조될 수 있다. 이때, 상기 유화 제형의 화장료 조성물로는 영양화장수, 에센스, 아이 크림, 영양 크림, 마사지 크림, 클렌징 크림, 클렌징 폼 등을 들 수 있으며, 상기 가용화 제형의 화장료 조성물로는 유연화장수, 수렴화장수, 클렌징 워터 등을 들 수 있다. 또한, 팩, 스프레이 또는 콘실 스틱 등의 형태로 제형화되어 피부과학 분야에서 통상적으로 사용되는 국소 적용 또는 전신 적용할 수 있는 보조제의 형태로 제조될 수 있음은 물론이다.In one example, the cosmetic composition according to the present invention described above may be prepared in an emulsion formulation or a solubilized formulation. At this time, the cosmetic composition of the emulsified formulations may include nutrient cosmetics, essences, eye creams, nutrition creams, massage creams, cleansing creams, cleansing foams, etc., and the cosmetic composition of the solubilized formulations, supple cosmetics, astringent cosmetics, cleansing Water, and the like. It is, of course, formulated in the form of a pack, spray or cone stick, and can be prepared in the form of adjuvants which can be applied topically or systemically as commonly used in the field of dermatology.
이때, 본 발명의 일 양태에 따른 화장료 조성물은 상기 글리세릴 글루코사이드 및 진세노사이드를 유효성분으로 포함하는 화장료 조성물을 제형 내, 0.001 내지 50 중량%로 포함될 수 있으며, 좋게는 0.01 내지 30.0 중량%, 보다 좋게는 0.01 내지 20.0 중량%로 포함될 수 있다. At this time, the cosmetic composition according to an aspect of the present invention may include a cosmetic composition comprising the glyceryl glucoside and ginsenoside as an active ingredient in the formulation, 0.001 to 50% by weight, preferably 0.01 to 30.0% by weight, More preferably 0.01 to 20.0% by weight.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예는 단지 예시적인 것이지 본 발명의 범위를 어떤 식으로든 제한하기 위한 것은 아니다. 또한 본 발명에서 각 성분의 사용량에 있어, 다른 정의가 없다면 중량(g) 단위를 기준으로 한다.Hereinafter, preferred examples are provided to aid in understanding the present invention. However, the following examples are provided only to make the present invention easier to understand, and the following examples are merely exemplary and are not intended to limit the scope of the present invention in any way. In addition, in the present invention, the amount of each component is used, based on the weight (g) unit unless otherwise defined.
(경피 흡수 측정)(Transdermal absorption measurement)
평가 1. Evaluation 1.
하기 실시예 및 비교예에서 제조된 화장료 조성물 각각을 무모 생쥐의 피부를 사용하여 피부투과 시험을 3회 수행하였다. 직경 7.5 ㎜의 피부표면에 시료를 각각 48 ㎕씩 주입하고, 경피흡수 기기(마이크로에트, 한손사(Microette, Hanson Co.))를 이용하여 24시간 후에 투과된 진세노사이드의 양을 고속 액체크로마토 그래피로 정량하여, 진세노사이드의 투과율(%)로 계산하였다(표 2 참조).Each of the cosmetic compositions prepared in the following Examples and Comparative Examples was subjected to three skin permeation tests using the skin of hairless mice. 48 μl of sample was injected into the skin surface of 7.5 mm in diameter, and the amount of ginsenoside permeated after 24 hours using a transdermal absorption device (Microette, Hanson Co.) was obtained by high-performance liquid chromatography. Quantitatively by graphy, it was calculated as the percent transmittance of ginsenosides (see Table 2).
HPLC분석기기 및 분석조건HPLC analysis equipment and analysis conditions
기기: Waters 2998 PDA detecter, 1525 pump,2707 autosamplerInstrument: Waters 2998 PDA detecter, 1525 pump, 2707 autosampler
컬럼: Sunfire C18 305um, 4.6 X150 mmColumn: Sunfire C18 305um, 4.6 X150 mm
검출기(detector): UV 203nmDetector: UV 203nm
유량(Flow rate): 1mL/minFlow rate: 1 mL / min
주입 부피(Injection volumn): 20ulInjection volumn: 20ul
조건: gradient(A:B, A;물, B;아세토나이트릴), 82:18(0~22분), 70:30(22~32분), 50:50(32~60분)Conditions: gradient (A: B, A; water, B; acetonitrile), 82:18 (0 to 22 minutes), 70:30 (22 to 32 minutes), 50:50 (32 to 60 minutes)
[수학식 1][Equation 1]
투과율(%) = (시험 후 투과된 진세노사이드의 함량/시험 전 진세노사이드의 함량)×100 Permeability (%) = (content of ginsenosides permeated after test / contents of ginsenosides before test) × 100
(피부 주름 개선 효과)(Skin wrinkle improvement)
평가 2. 콜라겐 합성 촉진Evaluation 2. Promoting Collagen Synthesis
하기 실시예 및 비교예에서 제조된 화장료 조성물 각각을 인간유래의 섬유아세포의 배양액에 첨가하여 세포수준에서 콜라겐 합성 촉진 효과를 실험하였다. 생합성된 콜라겐의 측정은 PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT)를 이용하여 정량하였다.Each of the cosmetic compositions prepared in the following Examples and Comparative Examples was added to the culture solution of human-derived fibroblasts to test collagen synthesis promoting effects at the cellular level. The biosynthetic collagen was measured using a PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT).
화장료 조성물 각각의 최종 농도가 10 ㎍/mL, 20 ㎍/mL가 되도록 하고, 양성 대조군인 비타민 C는 50 ㎍/㎖가 되도록 배지에 첨가하고, 음성 대조군(무첨가)을 각각 인간 유래의 섬유아세포(7×104 cells/㎠)의 배양 배지에 첨가하여 1일간 배양한 후, 배양액을 취하여 PICP EIA Kit로 각 농도에서 콜라겐 생합성 정도를 분광 광도계를 이용하여 450 nm에서 측정하였다. 이때, 콜라겐 생합성능은 음성 대조군에 대한 상대적인 합성능으로 증가율(%)을 계산하였다(표 3 참조).The final concentration of each cosmetic composition was 10 μg / mL and 20 μg / mL, and the positive control vitamin C was added to the medium so as to be 50 μg / ml, and a negative control (no addition) was added to each of fibroblasts derived from humans ( 7 × 10 4 cells / cm 2) were added to the culture medium and incubated for 1 day, and then the culture medium was taken and measured at 450 nm using a spectrophotometer at the concentration of collagen biosynthesis at each concentration using PICP EIA Kit. At this time, the collagen biosynthesis was calculated as the increase rate (%) relative to the negative control ability (see Table 3).
[수학식 2][Equation 2]
증가율(%) = {(시험물질의 흡광도/음성 대조군의 흡광도)×100}-100% Increase = {(absorbance of test substance / absorbance of negative control) × 100} -100
(피부 보습 효과)(Skin moisturizing effect)
평가 3. 단기 보습Evaluation 3. Short-term moisturizing
하기 실시예 및 비교예에서 제조된 화장료 조성물 각각을 이용하여 하기 표 7의 조성으로 영양 크림을 제조하고, 각각에 대한 피부 보습력을 평가하기 위하여, 단기 보습 시험을 실시하였다.Using each of the cosmetic compositions prepared in the following Examples and Comparative Examples to prepare a nourishing cream in the composition of Table 7, and to evaluate the skin moisturizing power for each, a short-term moisturizing test was performed.
각 대상의 하박 좌우를 비누로 세척한 후, 온도 20 ℃ 내외 및 습도 40 % 내외에서 피부를 적응시켰다. 피부 유연효과는 보습력 실험으로 함께 평가하였다. 하박 내측면 좌우에 4 x 3 ㎠의 직사각형으로 시험 부위를 정하였고 코네오미터(Corneometer, CM825)를 이용하여 피부 표면 전기용량(capacitance)을 3회 반복하여 측정하였다. After washing the left and right of each subject with soap, the skin was adapted to a temperature of about 20 ° C and a humidity of about 40%. Skin softening effect was evaluated with the moisturizing experiment. The test site was defined as a rectangle of 4 x 3 cm 2 on the left and right inner side of the lower chest, and the skin surface capacitance was measured three times using a coneometer (Corneometer, CM825).
각각의 시료 24 μL (2 ㎎/㎠)을 시험 부위에 도포하였다. 도포 6 시간 경과 후, 도포 전과 같은 방법으로 피부 표면 전기 용량을 3회 반복 측정하였다. 3회 반복 측정한 전기용량의 평균값을 구한 후, 이를 수분량으로 하였다. 도포 전의 초기 수분량과 무도포 부위의 수분량을 보정하여 수분 증감율을 구하였으며, 이를 바탕으로 화장료 조성물 각각의 피부 보습력을 판단하였다. 이때, 상기 수분 증감율은 하기 수학식 3을 통해 계산하였다(표 4 참조).24 μL (2 mg / cm 2) of each sample was applied to the test site. After 6 hours of application, the skin surface capacitance was measured three times in the same manner as before application. After calculating the average value of the capacitance measured three times, this was taken as the moisture content. Moisture increase / decrease rate was obtained by correcting the initial amount of moisture before application and the amount of moisture in the uncoated portion, and the skin moisturizing power of each cosmetic composition was determined based on this. At this time, the moisture increase and decrease rate was calculated through the following equation (3).
[수학식 3][Equation 3]
수분 증감률(%) =% Change in moisture =
│{[(Tdi-Td0)-(Ntdi-NTd0)]/[(Ntdi-NTd0)+Td0]}*100│ {[(Tdi-Td0)-(Ntdi-NTd0)] / [(Ntdi-NTd0) + Td0]} * 100│
Tdi = 시료 도포 부위의 n번째 측정값Tdi = nth measurement of the sample application site
Td0 = 시료 도포 부위의 before 측정값 Td0 = before measurement of sample application site
NTdi = 시료를 도포하지 않은 부위의 n번째 측정값 NTdi = nth measured value where no sample is applied
NTd0 = 시료를 도포하지 않은 부위의 before 측정값 NTd0 = before measurement of the area where the sample is not applied
(제형 안정성)(Formulation Stability)
평가 4. 변색 및 상분리 여부에 대한 육안 평가Evaluation 4. Visual evaluation of discoloration and phase separation
하기 실시예 및 비교예에서 제조된 화장료 조성물 각각을 이용하여 하기 표 7의 조성으로 영양 크림을 제조하고, 이의 제형 안정도를 비교하였다. 제형 안정도는 실온(20±2℃), 냉온항온조(4±2℃), 고온항온조(45±2℃) 및 사이클 챔버(Freeze-Thaw Chamber, -20 ℃에서 45 ℃를 1일 1회 주기로 순환)에 보관하고, 1주일 간격으로 각 시료의 변색 및 상분리 여부 등을 육안으로 관찰하였다(표 5 참조).Using a cosmetic composition prepared in the following Examples and Comparative Examples to prepare a nourishing cream in the composition of Table 7, and compared the formulation stability thereof. Formulation stability is circulated once daily at room temperature (20 ± 2 ℃), cold and thermostatic bath (4 ± 2 ℃), high temperature bath (45 ± 2 ℃) and cycle chamber (Freeze-Thaw Chamber, -20 ℃ to 45 ℃). ), And discoloration and phase separation of each sample at a weekly interval were visually observed (see Table 5).
(실시예 1-8) (Example 1-8)
하기 표 1의 조성으로 화장료 조성물을 제조한 후 상기의 방법으로 효능·효과를 평가하여, 그 결과를 하기 표 2 내지 3에 나타내었다. After preparing the cosmetic composition with the composition of Table 1, the efficacy and effect were evaluated by the above method, and the results are shown in Tables 2 to 3 below.
또한, 하기 표 7의 조성으로 영양 크림을 제조한 후 상기의 방법으로 단기 보습 평가 및 제형 안정성을 평가하여, 그 결과를 하기 표 4 내지 5에 나타내었다.In addition, after preparing the nourishing cream with the composition of Table 7 and evaluated the short-term moisturizing evaluation and formulation stability by the above method, the results are shown in Tables 4 to 5 below.
(비교예 1-3)(Comparative Example 1-3)
하기 표 1의 조성으로 조성물을 제조한 후 상기의 방법으로 효능·효과를 평가하여, 그 결과를 하기 표 2 내지 3에 나타내었다. After preparing the composition with the composition of Table 1, the efficacy and effect were evaluated by the above method, and the results are shown in Tables 2 to 3 below.
또한, 하기 표 7의 조성으로 영양 크림을 제조한 후 상기의 방법으로 단기 보습 평가 및 제형 안정성을 평가하여, 그 결과를 하기 표 4 내지 5에 나타내었다.In addition, after preparing the nourishing cream with the composition of Table 7 and evaluated the short-term moisturizing evaluation and formulation stability by the above method, the results are shown in Tables 4 to 5 below.
상기 표 2에 도시한 바에 따르면, 본 발명에 따른 화장료 조성물은 경피 투과율이 비교예 대비 현저하게 촉진됨을 확인할 수 있다. 또한 본 발명에 따른 화장료 조성물에 있어, 다가 알코올 및/또는 비이온 계면활성제를 더 포함함에 따라 이의 효과가 배가됨을 확인할 수 있다.As shown in Table 2, the cosmetic composition according to the present invention can be seen that the permeability is significantly promoted compared to the comparative example. In addition, in the cosmetic composition according to the present invention, it can be confirmed that the effect thereof is doubled by further including a polyhydric alcohol and / or a nonionic surfactant.
상기 표 3에 도시한 바에 따르면, 본 발명에 따른 화장료 조성물은 인간 유래의 섬유아세포에 대하여 우수한 콜라겐 합성능을 나타낼 뿐 아니라 양성 대조군으로 사용된 비타민 C의 경우보다 낮은 시험 농도에서 월등한 콜라겐 합성능을 나타냄을 알 수 있다.As shown in Table 3, the cosmetic composition according to the present invention not only shows excellent collagen synthesis ability for human-derived fibroblasts, but also superior collagen synthesis ability at a lower test concentration than that of vitamin C used as a positive control. It can be seen that.
이에, 본 발명에 따른 화장료 조성물은 피부 주름 개선 효과에 탁월하여, 피부 개선 효과의 극대화를 기대할 수 있다.Thus, the cosmetic composition according to the present invention can be excellent in the skin wrinkle improvement effect, can be expected to maximize the skin improvement effect.
더욱이, 상술된 본 발명에 따른 화장료 조성물의 상술된 효능·효과는 진세노사이드 또는 글리세릴 글루코사이드 단독을 포함하는 화장료 조성물 대비 놀라운 상승 효과에 해당한다.Moreover, the above-mentioned efficacy and effect of the cosmetic composition according to the present invention described above corresponds to a surprising synergistic effect compared to the cosmetic composition comprising ginsenoside or glyceryl glucoside alone.
상기 표 4에 도시한 바에 따르면, 본 발명에 따른 화장료 조성물은 진세노사이드 또는 글리세릴 글루코사이드 단독을 포함하는 화장료 조성물 대비 현저하게 향상된 단기 보습 효과를 나타냄을 알 수 있다. As shown in Table 4, it can be seen that the cosmetic composition according to the present invention shows a significantly improved short-term moisturizing effect compared to the cosmetic composition comprising ginsenoside or glyceryl glucoside alone.
더욱이, 보습 성분으로 알려진 글리세린을 더 포함함에 따라 최대 109.8% 이상의 상승효과를 나타낼 뿐 아니라 소정의 비이온 계면활성제를 더 포함함에 따라 최대 126.5% 이상의 상승효과를 나타낼 수 있음을 알 수 있다.Moreover, it can be seen that the addition of glycerin, also known as a moisturizing component, can exhibit a synergistic effect of up to 109.8% or more, as well as a synergistic effect of up to 126.5% or more by further including a predetermined nonionic surfactant.
상기 표 5에 도시한 바에 따르면, 본 발명에 따른 화장료 조성물은 온도에 제한없이 장시간이 경과함에도 불구하고 제형이 안정되도록 유지됨은 물론이거니와 카테킨 등에 의해 유발될 수 있는 제형의 변색을 초래하지 않음을 확인 할 수 있다. 그러나, 비교예의 경우 화장료 조성물의 제형 불안정은 물론이고, 변색이 관찰되었다.As shown in Table 5, the cosmetic composition according to the present invention is confirmed that the formulation remains stable even after a long time without limiting the temperature and does not cause discoloration of the formulation that can be caused by catechin and the like. can do. However, in the case of the comparative example as well as the formulation instability of the cosmetic composition, discoloration was observed.
요컨대, 본 발명에 따른 화장료 조성물은 피부의 섬유아세포의 콜라겐 합성을 촉진하고 피부줄기세포의 증식을 촉진하여 피부의 재생을 촉진시키고 주름을 개선하며 탄력을 증진시키고, 현저하게 향상된 피부 보습 효과로 피부결 개선 효과에 탁월함을 나타내어, 다양한 양태의 화장료 조성물에 응용되어 복합 기능성 화장품을 제공할 수 있을 것으로 기대된다.In short, the cosmetic composition according to the present invention promotes collagen synthesis of fibroblasts of the skin, promotes the proliferation of skin stem cells, promotes the regeneration of the skin, improves wrinkles, enhances elasticity, and improves the skin with a significantly improved skin moisturizing effect. It is expected to be excellent in the effect of improving the texture, and to be applied to cosmetic compositions of various embodiments to provide a composite functional cosmetic.
(제형예 1)(Formulation example 1)
하기 표 6의 조성으로 통상의 방법에 따라 화장수를 제조하였다.To the lotion was prepared according to a conventional method in the composition of Table 6.
(제형예 2)(Formulation Example 2)
하기 표 7의 조성으로 통상의 방법에 따라 영양 크림을 제조하였다.To the nutrition of the cream was prepared according to the conventional method in the composition shown in Table 7.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정하여 진다고 할 것이다.As described above in detail a specific part of the present invention, it is apparent to those skilled in the art that the specific technology is merely an embodiment, and the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the invention will be defined by the appended claims and equivalents thereof.
Claims (9)
- 글리세릴 글루코사이드 및 진세노사이드를 유효성분으로 포함하는 화장료 조성물.Cosmetic composition comprising glyceryl glucoside and ginsenoside as an active ingredient.
- 제 1항에 있어서,The method of claim 1,상기 진세노사이드는 Rb1, Rb2, Rb3, Rc, Rd, Rg1, Rg2, Rg3, Rg5, Rg6, Rh1, Rh2, Rh3, Rh4, Rk1 및 CK 에서 선택되는 것인 화장료 조성물.The ginsenoside is selected from Rb1, Rb2, Rb3, Rc, Rd, Rg1, Rg2, Rg3, Rg5, Rg6, Rh1, Rh2, Rh3, Rh4, Rk1 and CK.
- 제 1항에 있어서,The method of claim 1,상기 진세노사이드는 인삼, 홍삼, 백삼, 흑삼 또는 이들의 추출물로부터 수득된 것인 화장료 조성물.The ginsenoside is a cosmetic composition obtained from ginseng, red ginseng, white ginseng, black ginseng or extracts thereof.
- 제 1항에 있어서,The method of claim 1,다가 알코올을 더 포함하는 화장료 조성물.Cosmetic composition further comprising a polyhydric alcohol.
- 제 1항에 있어서,The method of claim 1,비이온 계면활성제를 더 포함하는 화장료 조성물.A cosmetic composition further comprising a nonionic surfactant.
- 제 1항에 있어서,The method of claim 1,상기 조성물은 피부 주름 개선용인 화장료 조성물.The composition is a cosmetic composition for improving skin wrinkles.
- 제 6항에 있어서,The method of claim 6,레티노이드, 토코페롤, 코엔자임 Q10, 알파-리포익산, 아세틸헥사펩타이드, 레티놀, 레티닐팔미테이트, 레티닐아세테이트, 콜라겐, 기네틴, 아쿠아노미드, 아데노신, 폴리에톡실레이티드레틴아마이드 및 노루풀 추출물에서 선택되는 하나 이상의 주름 개선 성분을 더 포함하는 것인 화장료 조성물.From retinoids, tocopherols, coenzyme Q10, alpha-lipoic acid, acetylhexapeptide, retinol, retinyl palmitate, retinyl acetate, collagen, geninetin, aquanomede, adenosine, polyethoxylatedretinamide, and roe deer extracts Cosmetic composition further comprises one or more wrinkle improvement ingredients selected.
- 제 1항에 있어서,The method of claim 1,상기 조성물은 피부 보습용인 화장료 조성물.The composition is a cosmetic composition for skin moisturizing.
- 제 8항에 있어서,The method of claim 8,제니스틴, 다이드진, 그리시틴, 제니스테인, 다이드제인 및 그리시테인에서 선택되는 하나 이상의 보습 성분을 더 포함하는 것인 화장료 조성물.A cosmetic composition further comprising at least one moisturizing component selected from zenithine, dydazine, glycithin, zenithine, dyedzein and glysteine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170050223A KR102044726B1 (en) | 2017-04-19 | 2017-04-19 | Composition for improving skin |
KR10-2017-0050223 | 2017-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018194359A1 true WO2018194359A1 (en) | 2018-10-25 |
Family
ID=63857144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/004477 WO2018194359A1 (en) | 2017-04-19 | 2018-04-18 | Skin-improving composition |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102044726B1 (en) |
WO (1) | WO2018194359A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3973974A4 (en) * | 2019-05-20 | 2023-05-10 | CJ Cheiljedang Corporation | Composition for increasing bioavailability and promoting absorption of ginsenosides in black ginseng extract |
EP4069215A4 (en) * | 2019-12-06 | 2024-01-17 | Jlabs Beauty LLC | Topical compositions containing rose oil and cannabidiol and methods of making and using the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050088741A (en) * | 2004-03-03 | 2005-09-07 | 소망화장품주식회사 | Cosmetic composition comprising saponin compounds containing ginsenoside rg2 for protecting skin |
US20090130223A1 (en) * | 2006-04-27 | 2009-05-21 | Ute Breitenbach | Cosmetic preparation with aquaporin stimulators and the use thereof |
KR101233833B1 (en) * | 2009-09-29 | 2013-02-18 | 홍성빈 | COSMETIC COMPOSITION CONTAINING GINSENOSIDE Re FOR IMPROVEMENT OF SKIN |
KR20140112612A (en) * | 2013-03-11 | 2014-09-24 | 대한민국(농촌진흥청장) | Moisturizer compositions containing extracts of crude drug |
WO2015152103A1 (en) * | 2014-03-31 | 2015-10-08 | カーリットホールディングス株式会社 | Glyceryl glucoside-containing composition and method for producing same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101574558B1 (en) * | 2013-12-31 | 2015-12-04 | (주)에이씨티 | Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts |
-
2017
- 2017-04-19 KR KR1020170050223A patent/KR102044726B1/en active IP Right Grant
-
2018
- 2018-04-18 WO PCT/KR2018/004477 patent/WO2018194359A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050088741A (en) * | 2004-03-03 | 2005-09-07 | 소망화장품주식회사 | Cosmetic composition comprising saponin compounds containing ginsenoside rg2 for protecting skin |
US20090130223A1 (en) * | 2006-04-27 | 2009-05-21 | Ute Breitenbach | Cosmetic preparation with aquaporin stimulators and the use thereof |
KR101233833B1 (en) * | 2009-09-29 | 2013-02-18 | 홍성빈 | COSMETIC COMPOSITION CONTAINING GINSENOSIDE Re FOR IMPROVEMENT OF SKIN |
KR20140112612A (en) * | 2013-03-11 | 2014-09-24 | 대한민국(농촌진흥청장) | Moisturizer compositions containing extracts of crude drug |
WO2015152103A1 (en) * | 2014-03-31 | 2015-10-08 | カーリットホールディングス株式会社 | Glyceryl glucoside-containing composition and method for producing same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3973974A4 (en) * | 2019-05-20 | 2023-05-10 | CJ Cheiljedang Corporation | Composition for increasing bioavailability and promoting absorption of ginsenosides in black ginseng extract |
EP3973975A4 (en) * | 2019-05-20 | 2023-06-21 | CJ Cheiljedang Corporation | Anti-influenza virus composition, composition for treating respiratory diseases, and anti-aging composition, comprising dark ginseng extract |
EP4069215A4 (en) * | 2019-12-06 | 2024-01-17 | Jlabs Beauty LLC | Topical compositions containing rose oil and cannabidiol and methods of making and using the same |
Also Published As
Publication number | Publication date |
---|---|
KR20180117299A (en) | 2018-10-29 |
KR102044726B1 (en) | 2019-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3334501B1 (en) | Compositions including ampelopsis grossedentata and albizia julibrissin extracts and methods of use | |
CA2587665C (en) | Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum. | |
WO2011122869A2 (en) | Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care | |
KR100793912B1 (en) | Use of oligosaccharides to stimulate beta-endorphin production | |
JP4425163B2 (en) | Anti-aging cosmetics | |
KR20120000880A (en) | Cosmetic composition comprising naturalplant extract for alleviating atopic dermatitis | |
KR101993699B1 (en) | Composition for improving skin | |
WO2022177215A1 (en) | Method for promoting antioxidant activity of purple tea leaves | |
KR20140003198A (en) | Composition of skin external application containing compound k | |
RU2571690C2 (en) | Compositions containing paulownin and/or paulownia extracts and using same | |
KR101460569B1 (en) | Cosmetic composition comprising of gingenoside F2 for skin wrinkle improvement, skin whitening or anti-acne | |
KR20130114502A (en) | Cosmetic compositions comprising the extract of cornus officinalis as an active ingredient | |
KR20140096753A (en) | Skin moisturizing composition comprising Platycodin grandiflorum containing platycodin D | |
WO2018194359A1 (en) | Skin-improving composition | |
KR100742267B1 (en) | Extract of Chrysanthemum morifolium Ramat, the preparation method thereof and the cosmetic composition comprising the same for whitening | |
KR20190023200A (en) | Low irritating cosmetic composition for skin whitening | |
KR102062854B1 (en) | Cosmetic composition containing active fractions of Rubus coreanus MIQ root | |
KR20130114493A (en) | Cosmetic compositions comprising the extract of dendropanax morbiferum as an active ingredient | |
KR102154927B1 (en) | A cosmetic composition for anti-aging, anti-oxidant, skin regeneration comprising chlorogenic acid, ferulic acid, resveratrol, and Streptococcus thermophilus fermented extract | |
KR100602684B1 (en) | Cosmetic composition comprising extract of erigeron breviscapus for whitening | |
KR20220126653A (en) | The composition comprising cannabigerol | |
KR101860001B1 (en) | Cosmetic composition comprising bamboo stem extract as an active ingredient | |
CN106620295B (en) | Chinese herbal medicine composition | |
KR101620950B1 (en) | Manufacturing method of the Cosmetic Composition for Regenerating Skin Cell, Anti-oxidant, Anti-bacterial effect and Anti-inflammatory of the skin and the Cosmetic Composition manufactured by the same | |
KR102690709B1 (en) | Cosmetic composition containing fermented complex extracts of camellia flower, evening primrose flower, blue lotus flower, plum blossom and elderflower |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18788129 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 04/02/2020) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18788129 Country of ref document: EP Kind code of ref document: A1 |